Peripheral interventions market seen reaching $15.28 billion by 2030

The Business Research Company says the peripheral interventions market will grow from $10 billion in 2025 to $10.91 billion in 2026, then to $15.28 billion by 2030. The report points to rising demand for minimally invasive vascular procedures, with North America leading now and Asia-Pacific expected to grow fastest.

Why it matters: - Peripheral interventions are becoming a bigger part of vascular care as hospitals and outpatient centers look for less invasive ways to diagnose and treat blood vessel disease. - The market’s projected rise signals more demand for catheter-based tools, stents and other devices used to restore blood flow outside the heart and brain. - Faster adoption could affect reimbursement, procedure volumes and investment in endovascular technology across major regions.

What happened: - The Business Research Company published a report on the peripheral interventions market on August 24, 2026. - The report estimates the market will rise from $10 billion in 2025 to $10.91 billion in 2026, a 9.1% compound annual growth rate. - The report projects the market will reach $15.28 billion by 2030, with an 8.8% compound annual growth rate. - North America held the largest market share in 2025. - Asia-Pacific is expected to post the fastest growth over the forecast period.

The details: - Peripheral interventions use minimally invasive techniques to diagnose and treat blood vessel conditions outside the heart and brain, including arteries in the limbs and abdomen. - These procedures typically use image guidance to improve blood flow and avoid open surgery. - Market growth is being driven by more peripheral artery disease cases, an aging population with vascular issues, better awareness of limb ischemia, advances in catheter-based technologies and improved reimbursement for endovascular treatments. - The report also cites a growing preference for minimally invasive procedures, faster progress in stents and guide wires, expansion of ambulatory surgical centers, higher healthcare spending in emerging economies and demand for quicker recovery protocols. - The report identifies several trends shaping the market, including broader use of drug-eluting and covered stents, image-guided endovascular techniques, atherectomy and thrombectomy devices, and outpatient peripheral interventions. - A June 2024 American Society of Plastic Surgeons report said about 25.4 million minimally invasive procedures were performed in the US in 2023, up 7% from a year earlier. - The report covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa in addition to North America and Asia-Pacific. - The 2026 report edition includes market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, and updated graphics and tables. - The company also offers a free sample of the report and access to the full report through its website. - Download the free sample - View the full market report

Between the lines: - The report’s growth outlook tracks a broader shift in healthcare toward procedures that reduce trauma, pain and recovery time. - The strongest near-term opportunity appears to be in technologies that support outpatient treatment and faster recovery, not just the core procedure itself. - The regional split suggests mature demand in North America and more room for adoption and infrastructure buildout across Asia-Pacific.

What's next: - The market is likely to keep expanding as device makers push new stents, wires and image-guided tools into clinical use. - Growth in ambulatory surgical centers and outpatient care could broaden where peripheral interventions are performed. - Investors and healthcare providers will likely watch reimbursement policy, procedure volumes and adoption of minimally invasive vascular therapies as key indicators.